InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Plasmocin® - Mycoplasma Elimination Reagent | Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the sti... | 2022 | J Exp Clin Cancer Res. | Rigiracciolo D.C. et al. | DOI: 10.1186/s13046-022-02396-0 |
ODN 1668 - TLR9 ligand | ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides... | 2022 | J Lipid Res. | Deng M. et al. | DOI: 10.1016/j.jlr.2022.100237 |
TDB | Mincle-binding DNA aptamer demonstrates therapeutic potential in a model of i... | 2022 | Mol Ther Nucleic Acids | Stephens M. et al. | DOI: 10.1016/j.omtn.2022.05.026 |
Anti-mouse Mincle (CLEC4E) antibody | Mincle-binding DNA aptamer demonstrates therapeutic potential in a model of i... | 2022 | Mol Ther Nucleic Acids | Stephens M. et al. | DOI: 10.1016/j.omtn.2022.05.026 |
Blasticidin | Therapeutical Significance of Serpina3n Subsequent Cerebral Ischemia via Cyto... | 2022 | Biomed Res Int. | Aslam M.S. et al. | DOI: 10.1155/2022/1557010 |
Puromycin | Therapeutical Significance of Serpina3n Subsequent Cerebral Ischemia via Cyto... | 2022 | Biomed Res Int. | Aslam M.S. et al. | DOI: 10.1155/2022/1557010 |
EndoFit™ OVA protein | Antigen bivalency of antigen-presenting cell-targeted vaccines increases B ce... | 2022 | Cell Rep. | Hinke D.M. et al. | DOI: 10.1016/j.celrep.2022.110901 |
AddaVax™ | Antigen bivalency of antigen-presenting cell-targeted vaccines increases B ce... | 2022 | Cell Rep. | Hinke D.M. et al. | DOI: 10.1016/j.celrep.2022.110901 |
OVA peptides | Antigen bivalency of antigen-presenting cell-targeted vaccines increases B ce... | 2022 | Cell Rep. | Hinke D.M. et al. | DOI: 10.1016/j.celrep.2022.110901 |
ODN TTAGGG (A151) | Neutrophil extracellular traps mediate m6A modification and regulates sepsis-... | 2022 | Int J Biol Sci. | Zhang H. et al. | DOI: 10.7150/ijbs.69141 |
ODN 2395 - TLR9 ligand | DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nonto... | 2022 | Small | Lucas C.R. et al. | DOI: 10.1002/smll.202108063 |
Pam3CSK4 | Decreased leukocyte exhaustion is associated with decreased IFN-β and increas... | 2022 | Cytokine | Shruthi S. et al. | DOI: 10.1016/j.cyto.2022.155918 |
THP1-Null Cells | Rapid Hypothesis Testing in Candida albicans Clinical Isolates Using a Clonin... | 2022 | Microbiol Spectr. | Liu J. et al. | DOI: 10.1128/spectrum.02630-21 |
PMA - Phorbol myristate acetate | Rapid Hypothesis Testing in Candida albicans Clinical Isolates Using a Clonin... | 2022 | Microbiol Spectr. | Liu J. et al. | DOI: 10.1128/spectrum.02630-21 |
CR3022-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes | Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals... | 2022 | Sci Rep. | Thomas S.N. et al. | DOI: 10.1038/s41598-022-12869-z |
Primocin® | The unfolded protein response to PI*Z alpha-1 antitrypsin in human hepatocell... | 2022 | Hepatol Commun. | Lu Y. et al. | DOI: 10.1002/hep4.1997 |
LPS-EB VacciGrade™ | The unfolded protein response to PI*Z alpha-1 antitrypsin in human hepatocell... | 2022 | Hepatol Commun. | Lu Y. et al. | DOI: 10.1002/hep4.1997 |
Nigericin | NLRP3 licenses NLRP11 for inflammasome activation in human macrophages. | 2022 | Nat Immunol. | Gangopadhyay A. et al. | DOI: 10.1038/s41590-022-01220-3 |
FSL-1 | NLRP3 licenses NLRP11 for inflammasome activation in human macrophages. | 2022 | Nat Immunol. | Gangopadhyay A. et al. | DOI: 10.1038/s41590-022-01220-3 |
Pam3CSK4 | NLRP3 licenses NLRP11 for inflammasome activation in human macrophages. | 2022 | Nat Immunol. | Gangopadhyay A. et al. | DOI: 10.1038/s41590-022-01220-3 |